Only a small portion (10% to 25%) binds to proteins in the blood, allowing most of the drug to be available for pain relief and fever reduction, as explained by Gerriets et al
At 100 IU/L, this study predicts about half would have a loss and half would have a sustained pregnancy
Four out of six studies found meaningful improvements, particularly in working memory, with daily doses ranging from 6 to 20 grams
Recent clinical trials on glutamine metabolism inhibition mainly focuses on using CB-839 to target glutaminase (NCT02071862, NCT02071888 and NCT02071927 for solid tumors, lymphoid, and myeloid malignancies respectively) [24, 62]
This targeted delivery significantly increases local drug concentration while minimizing systemic toxicity